Rapport Therapeutics, Inc. Common Stock (RAPP)

10.27

(0.88%)

Net Income Summary of Rapport Therapeutics, Inc. Common Stock

  • Rapport Therapeutics, Inc. Common Stock's latest annual net income in 2023 was -34.78 Million USD , down -226.57% from previous year.
  • Rapport Therapeutics, Inc. Common Stock's latest quarterly net income in 2024 Q2 was -18.12 Million USD , up 20.06% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported an annual net income of -10.65 Million USD in 2022, down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock reported a quarterly net income of -22.66 Million USD for 2024 Q1, down -67.68% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported a quarterly net income of -34.78 Million USD for 2023 FY, down -226.57% from previous quarter.

Annual Net Income Chart of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Historical Annual Net Income of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Year Net Income Net Income Growth
2023 -34.78 Million USD -226.57%
2022 -10.65 Million USD 0.0%

Peer Net Income Comparison of Rapport Therapeutics, Inc. Common Stock

Name Net Income Net Income Difference